Home > Knowledge > Content
Sep 20, 2017

Although  some patients had a dose of up to 150 mg in the dose range study, some  patients had a dose of up to 400 mg in a single dose study, but there  was no experience with overrexamine overdose in patients with multiple  myeloma. The dose-limiting toxicity in these studies is essentially hematological in toxicity. In the event of overdose, recommended treatment is recommended.